Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

DNA Vaccines: Their Formulations, Engineering and Delivery
Michael Kozak, Jiafen Hu
Vaccines (2024) Vol. 12, Iss. 1, pp. 71-71
Open Access | Times Cited: 34
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 21
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 10
Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies
Zongjie Wang, Shana O. Kelley
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, et al.
Blood (2024) Vol. 143, Iss. 18, pp. 1856-1872
Open Access | Times Cited: 6
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
Dasun Fernando, Afsar U. Ahmed, Bryan Williams
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Immunostimulatory effects of thermal ablation: Challenges and future prospects
Peng Liu, Zhigang Wei, Xin Ye
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 531-539
Open Access | Times Cited: 4
Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?
Qingyang Liu, Peihua Wu, Jun Lei, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135541-135541
Closed Access | Times Cited: 4
Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment
Ιωάννα Αγγελετοπούλου, Spyridon Pantzios, Christos Triantos
Cancers (2025) Vol. 17, Iss. 3, pp. 376-376
Open Access
Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response
Arpita Balakrishnan, Gabriela Winiarek, Olga Hołówka, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Effective design of therapeutic nanovaccines based on tumor neoantigens
Weilin Wang, Yujia Zhai, Xiaoye Yang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 17-35
Closed Access
CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View
Sara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
TCR-T cell therapy for solid tumors: challenges and emerging solutions
Wanjun He, Kai Cui, Muhammad Asad Farooq, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
T-cell receptor dynamics in digestive system cancers: a multi-layer machine learning approach for tumor diagnosis and staging
Changjin Yuan, Bin Wang, Hong Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bioinspired Membrane‐Based Cancer Vaccines for Immunotherapy: Progress and Perspectives
Ying Miao, Jianlin Ge, Longyi Zheng, et al.
Small (2025)
Closed Access
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture
Joseph Zenga, Musaddiq Awan, Anne Frei, et al.
Translational Oncology (2024) Vol. 42, pp. 101899-101899
Open Access | Times Cited: 2
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma
Christy Los, Sebastian Klobuch, John B.A.G. Haanen
The Cancer Journal (2024) Vol. 30, Iss. 2, pp. 113-119
Closed Access | Times Cited: 2
Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer
Zuhair Chaudhry, Anik Boyadzhyan, Kayvan Sasaninia, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 46-46
Open Access | Times Cited: 2
Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy
Jilong Wang, Chenghu Wu, Yiran Wang, et al.
Biomaterials (2024) Vol. 311, pp. 122710-122710
Closed Access | Times Cited: 1
Understanding and Therapeutic Application of Immune Response in Major Histocompatibility Complex (MHC) Diversity Using Multimodal Artificial Intelligence
Yasunari Matsuzaka, Ryu Yashiro
BioMedInformatics (2024) Vol. 4, Iss. 3, pp. 1835-1864
Open Access | Times Cited: 1
Prospects and challenges of neoantigen applications in oncology
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top